Clinical trial
Donepezil Treatment of Psychotic Symptoms in Dementia Patients
NCT00190021 · Beersheva Mental Health Center, Other · Unknown status
Key facts
| NCT number | NCT00190021 |
|---|---|
| Title | Donepezil Treatment of Psychotic Symptoms in Dementia Patients |
| Official title | Donepezil as Add-On Treatment of Psychotic Symptoms in Patients With Dementia of the Alzheimer's Type |
| Lead sponsor | Beersheva Mental Health Center, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dementia of Alzheimer Type |
| Intervention type | Drug |
| Interventions | donepezil |
| Enrollment | 80 |
| First posted | Sep 19, 2005 |
| Last update posted | Sep 8, 2010 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: